Getting Rihanna’s number, Merck’s Big Drug Deal

Good day for unlisted numbers, Bad day for alternative medicines

GOOD DAY FOR: Unlisted numbers, after the entertainment program Extra published the cellphone numbers of singers Rihanna and Chris Brown. The numbers were printed on court documents that the program put up on screen and, apparently, forgot to blur out. (The Inquisitr)

BAD DAY FOR: Alternative medicines, after U.S. pharmaceutical giant Merck agreed to buy rival Schering-Plough for $41.1 billion, making Merck the second-largest U.S. drugmaker, after Pfizer. Earlier this year, Pfizer offered $62 billion for drugmaker Wyeth. “It clearly is a year of mergers for pharmaceutical companies,” said Natixis Securities analyst Philippe Lanone. (Bloomberg)

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up